Browse by article | Browse by volume |
Heroin Addiction and Related Clinical Problems: 2014, 16, 4 (pages: 15 - 24)
Maremmani A.G.I., Bacciardi S., Rugani F., Rovai L., Massimetti E., Gazzarrini D., Dell'Osso L., Pani P.P., Pacini M., and Maremmani I.
Summary: Objective. The aim of this naturalistic (observational) controlled cohort study was to compare the long-term outcomes of treatment-resistant heroin addicts with (HA+BDZ) and without (HA-BDZ) comorbid benzodiazepine (BDZ) severe addiction. Method. 63 HA-BDZ and 14 HA+BDZ patients were monitored prospectively along an enhanced methadone maintenance treatment programme (MMTP). HA+BDZ patients were treated, also, with clonazepam maintenance treatment (CMT). Results. Survival-in-treatment rates were no different in HA+BDZ and HA-BDZ patients. HA+BDZ patients showed better outcome results than HA-BDZ patients. HA+BDZ patients needed a higher methadone dosage in the stabilization phase. Conclusions. This study supports the possibility to use methadone maintenance and clonazepam maintenance combination in heroin-addicted patients with comorbid severe BDZ dependence.
EUROPAD - European Opiate Addiction Treatment Association Brussels, Belgium, EU P. IVA 01681650469 – Codice Fiscale 94002580465 Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org |